Ireland has temporarily suspended the rollout of the AstraZeneca coronavirus vaccine following reports of blood clots in adults who received the shot in Norway.
Irish health minister Stephen Donnelly said in a tweet on Sunday the decision was “based on new information from Norway that emerged late last night”, adding that this was a “precautionary step”.
Three health workers in Norway who had recently received the AstraZeneca COVID-19 vaccine were being treated in hospital for bleeding, blood clots and a low count of blood platelets, its health authorities said on Saturday.
The World Health Organization (WHO) has backed the use of the vaccine and said no causal link has been established between the use of the vaccine and clotting.
Al Jazeera's Jonah Hull reports from London, UK.
- Subscribe to our channel: http://aje.io/AJSubscribe
- Follow us on Twitter: https://twitter.com/AJEnglish
- Find us on Facebook: https://www.facebook.com/aljazeera
- Check our website: https://www.aljazeera.com/
#Ireland #AstraZeneca #Covid-19Vaccine
Irish health minister Stephen Donnelly said in a tweet on Sunday the decision was “based on new information from Norway that emerged late last night”, adding that this was a “precautionary step”.
Three health workers in Norway who had recently received the AstraZeneca COVID-19 vaccine were being treated in hospital for bleeding, blood clots and a low count of blood platelets, its health authorities said on Saturday.
The World Health Organization (WHO) has backed the use of the vaccine and said no causal link has been established between the use of the vaccine and clotting.
Al Jazeera's Jonah Hull reports from London, UK.
- Subscribe to our channel: http://aje.io/AJSubscribe
- Follow us on Twitter: https://twitter.com/AJEnglish
- Find us on Facebook: https://www.facebook.com/aljazeera
- Check our website: https://www.aljazeera.com/
#Ireland #AstraZeneca #Covid-19Vaccine
- Category
- World
- Tags
- ireland latest news, coronavirus deaths, coronavirus news
Sign in or sign up to post comments.
Be the first to comment